Market Overview:
The global desonide market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of skin diseases, rising awareness about skin care, and growing demand for desonide-based products. The global desonide market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into cream, ointment, lotion, foaming agent gel. The cream segment is expected to account for a major share of the global desonide market in 2018 owing to its high usage in various applications such as eczema and dermatitis.
Product Definition:
A synthetic corticosteroid used to treat various skin conditions, including eczema and psoriasis. It is also effective in the treatment of seborrhea and atopic dermatitis.
Cream:
Cream is a topical medication used for the treatment of skin conditions such as psoriasis, eczema and acne. It contains minoxidil, which is an anti-inflammatory drug that works by reducing redness and swelling caused by skin irritation. The cream can be applied to affected areas multiple times a day; it does not have to be washed off like other medications.
Ointment:
Ointment is a topical medication used for the treatment of skin diseases and injuries. It is available in different forms such as creams, gels, oils and lotions. Ointments are also useful for treating minor burns and can be used as first aid on cuts to reduce infection. The active ingredients in ointments include anti-inflammatory drugs that help reduce swelling & redness of skin along with moisturizers to soften it up again.
Application Insights:
On the basis of application, the global desonide market is segmented into eczema, dermatitis, allergies and rash. The eczema segment dominated the overall market in terms of revenue share in 2017. This can be attributed to increasing prevalence of atopic dermatitis coupled with rising awareness about early diagnosis and treatment options. As per a study published by NCBI in 2018, around 40% to 60% people have some degree of skin sensitivity after they are exposed to any allergen for the first time. Thus it is important for patients suffering from allergic rhinitis or asthma to seek medical consultation as soon as possible so that appropriate treatment can be started right away without waiting for an allergic reaction on exposure to a new allergen.
The allergy segment is expected register significant growth over the forecast period due largely on growing incidence rate of severe reactions suffered by people who are sensitive or immune-compromised against various drugs such as penicillin antibiotics.
Regional Analysis:
North America dominated the global desonide market in 2017. The presence of major players, favorable reimbursement policies, and increasing awareness about early diagnosis are some factors driving the regional market growth. For instance, in 2015, Allergan received approval for its new drug application for Desonide Cream through an expedited review process called Accelerated Approval (AA). This product is now available as a generic drug and is sold under different brand names such as TIDD or Actonel.
Asia Pacific region is expected to witness lucrative growth over the forecast period owing to rising disposable income coupled with growing consumer awareness about various treatment options available for dermatoses including natural products like desonide cream/ointments/lotions/gels etc.
Growth Factors:
- Increasing incidence of skin diseases: The increasing incidence of skin diseases is one of the key growth drivers for the desonide market. Desonide is a potent anti-inflammatory and immunosuppressive agent, which makes it an ideal treatment option for various skin conditions.
- Rising awareness about desonide: There is a growing awareness about the benefits of desonide among healthcare professionals and patients alike. This is likely to boost demand for this drug in the coming years.
- Growing use of topical corticosteroids: The growing use of topical corticosteroids across all age groups is another major factor driving growth in the desonide market. Topical corticosteroids are considered as first-line therapies for various dermatological conditions and are preferred over oral steroids due to their fewer side effects profile.
- Technological advancements in dermal delivery systems: The technological advancements in dermal delivery systems have led to the development of novel formulations containing higher concentrations of active ingredients with improved patient compliance rates.. This is likely to fuel demand for desonide in the coming years.. 5) Expanding distribution channels: A number if pharmaceutical companies are expanding their distribution channels by partnering with regional distributors to tap into new markets
Scope Of The Report
Report Attributes
Report Details
Report Title
Desonide Market Research Report
By Type
Cream, Ointment, Lotion, Foaming Agent, Gel
By Application
Eczema, Dermatitis, Allergies, Rash
By Companies
Galderma, Taro, Aleor Dermaceuticals, Encube Ethicals, Glenmark Pharms, Perrigo, Teligent Pharma, Huapont Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
156
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Desonide Market Report Segments:
The global Desonide market is segmented on the basis of:
Types
Cream, Ointment, Lotion, Foaming Agent, Gel
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Eczema, Dermatitis, Allergies, Rash
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Galderma
- Taro
- Aleor Dermaceuticals
- Encube Ethicals
- Glenmark Pharms
- Perrigo
- Teligent Pharma
- Huapont Pharma
Highlights of The Desonide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cream
- Ointment
- Lotion
- Foaming Agent
- Gel
- By Application:
- Eczema
- Dermatitis
- Allergies
- Rash
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Desonide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Desonide is a topical corticosteroid medication used to treat various skin conditions. It is available as a cream, ointment, or lotion. Desonide works by reducing the inflammation and swelling caused by these conditions.
Some of the major players in the desonide market are Galderma, Taro, Aleor Dermaceuticals, Encube Ethicals, Glenmark Pharms, Perrigo, Teligent Pharma, Huapont Pharma.
The desonide market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Desonide Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Desonide Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Desonide Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Desonide Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Desonide Market Size & Forecast, 2018-2028
4.5.1 Desonide Market Size and Y-o-Y Growth
4.5.2 Desonide Market Absolute $ Opportunity
Chapter 5 Global Desonide Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Desonide Market Size Forecast by Type
5.2.1 Cream
5.2.2 Ointment
5.2.3 Lotion
5.2.4 Foaming Agent
5.2.5 Gel
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Desonide Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Desonide Market Size Forecast by Applications
6.2.1 Eczema
6.2.2 Dermatitis
6.2.3 Allergies
6.2.4 Rash
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Desonide Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Desonide Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Desonide Analysis and Forecast
9.1 Introduction
9.2 North America Desonide Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Desonide Market Size Forecast by Type
9.6.1 Cream
9.6.2 Ointment
9.6.3 Lotion
9.6.4 Foaming Agent
9.6.5 Gel
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Desonide Market Size Forecast by Applications
9.10.1 Eczema
9.10.2 Dermatitis
9.10.3 Allergies
9.10.4 Rash
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Desonide Analysis and Forecast
10.1 Introduction
10.2 Europe Desonide Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Desonide Market Size Forecast by Type
10.6.1 Cream
10.6.2 Ointment
10.6.3 Lotion
10.6.4 Foaming Agent
10.6.5 Gel
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Desonide Market Size Forecast by Applications
10.10.1 Eczema
10.10.2 Dermatitis
10.10.3 Allergies
10.10.4 Rash
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Desonide Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Desonide Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Desonide Market Size Forecast by Type
11.6.1 Cream
11.6.2 Ointment
11.6.3 Lotion
11.6.4 Foaming Agent
11.6.5 Gel
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Desonide Market Size Forecast by Applications
11.10.1 Eczema
11.10.2 Dermatitis
11.10.3 Allergies
11.10.4 Rash
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Desonide Analysis and Forecast
12.1 Introduction
12.2 Latin America Desonide Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Desonide Market Size Forecast by Type
12.6.1 Cream
12.6.2 Ointment
12.6.3 Lotion
12.6.4 Foaming Agent
12.6.5 Gel
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Desonide Market Size Forecast by Applications
12.10.1 Eczema
12.10.2 Dermatitis
12.10.3 Allergies
12.10.4 Rash
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Desonide Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Desonide Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Desonide Market Size Forecast by Type
13.6.1 Cream
13.6.2 Ointment
13.6.3 Lotion
13.6.4 Foaming Agent
13.6.5 Gel
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Desonide Market Size Forecast by Applications
13.10.1 Eczema
13.10.2 Dermatitis
13.10.3 Allergies
13.10.4 Rash
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Desonide Market: Competitive Dashboard
14.2 Global Desonide Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Galderma
14.3.2 Taro
14.3.3 Aleor Dermaceuticals
14.3.4 Encube Ethicals
14.3.5 Glenmark Pharms
14.3.6 Perrigo
14.3.7 Teligent Pharma
14.3.8 Huapont Pharma
